Back to search results

A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL

Abroad (travel likely)RecruitingPHASE4

Conditions

Diabetic Foot Ulcer (DFU) · Venous Leg Ulcer (VLU)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Midland Florida Clinical Research Center, DeLand, Florida, United States

  • Pharmakon Medical Research, Palm Beach Gardens, Florida, United States

  • Vital Medical Research, Sweetwater, Florida, United States

  • EMbassy Research Network, Bloomfield Township, Michigan, United States

  • US Foot and Ankle Specialists-Cary Satellite Site, Cary, North Carolina, United States

  • US Foot and Ankle Specialists, Raleigh, North Carolina, United States

  • US Foot and Ankle Specialists, Blue Ash, Ohio, United States

  • Lower Extremity Institute for Research and Therapy, Boardman, Ohio, United States

  • Perfizien Clinical Research, LLC., Houston, Texas, United States

  • Foot and Ankle Specialists of the Mid-Atlantic, Salem, Virginia, United States

Study leads

  • Stan Andrews, MS

    Study Director

    Professional Education and Research Institute

View source on ClinicalTrials.gov(opens in a new tab)